575 related articles for article (PubMed ID: 19297174)
1. Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors.
Forghieri M; Laggner C; Paoli P; Langer T; Manao G; Camici G; Bondioli L; Prati F; Costantino L
Bioorg Med Chem; 2009 Apr; 17(7):2658-72. PubMed ID: 19297174
[TBL] [Abstract][Full Text] [Related]
2. Structure-based optimization of benzoic acids as inhibitors of protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase.
Maccari R; Ottanà R; Ciurleo R; Paoli P; Manao G; Camici G; Laggner C; Langer T
ChemMedChem; 2009 Jun; 4(6):957-62. PubMed ID: 19288492
[TBL] [Abstract][Full Text] [Related]
3. 5-Arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors.
Ottanà R; Maccari R; Ciurleo R; Paoli P; Jacomelli M; Manao G; Camici G; Laggner C; Langer T
Bioorg Med Chem; 2009 Mar; 17(5):1928-37. PubMed ID: 19217304
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells.
Ottanà R; Maccari R; Mortier J; Caselli A; Amuso S; Camici G; Rotondo A; Wolber G; Paoli P
Eur J Med Chem; 2014 Jan; 71():112-27. PubMed ID: 24287560
[TBL] [Abstract][Full Text] [Related]
5. Cellular inhibition of protein tyrosine phosphatase 1B by uncharged thioxothiazolidinone derivatives.
Stuible M; Zhao L; Aubry I; Schmidt-Arras D; Böhmer FD; Li CJ; Tremblay ML
Chembiochem; 2007 Jan; 8(2):179-86. PubMed ID: 17191286
[TBL] [Abstract][Full Text] [Related]
6. Formylchromone derivatives as irreversible and selective inhibitors of human protein tyrosine phosphatase 1B. Kinetic and modeling studies.
Shim YS; Kim KC; Lee KA; Shrestha S; Lee KH; Kim CK; Cho H
Bioorg Med Chem; 2005 Feb; 13(4):1325-32. PubMed ID: 15670940
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity.
Navarrete-Vazquez G; Paoli P; León-Rivera I; Villalobos-Molina R; Medina-Franco JL; Ortiz-Andrade R; Estrada-Soto S; Camici G; Diaz-Coutiño D; Gallardo-Ortiz I; Martinez-Mayorga K; Moreno-Díaz H
Bioorg Med Chem; 2009 May; 17(9):3332-41. PubMed ID: 19362487
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 2,4,6-trihydroxychalcone derivatives as novel protein tyrosine phosphatase 1B inhibitors.
Sun LP; Gao LX; Ma WP; Nan FJ; Li J; Piao HR
Chem Biol Drug Des; 2012 Oct; 80(4):584-90. PubMed ID: 22805439
[TBL] [Abstract][Full Text] [Related]
9. The development of potent non-peptidic PTP-1B inhibitors.
Dufresne C; Roy P; Wang Z; Asante-Appiah E; Cromlish W; Boie Y; Forghani F; Desmarais S; Wang Q; Skorey K; Waddleton D; Ramachandran C; Kennedy BP; Xu L; Gordon R; Chan CC; Leblanc Y
Bioorg Med Chem Lett; 2004 Feb; 14(4):1039-42. PubMed ID: 15013019
[TBL] [Abstract][Full Text] [Related]
10. Protein tyrosine phosphatase 1B inhibitors for diabetes.
Johnson TO; Ermolieff J; Jirousek MR
Nat Rev Drug Discov; 2002 Sep; 1(9):696-709. PubMed ID: 12209150
[TBL] [Abstract][Full Text] [Related]
11. Allele-specific inhibitors of protein tyrosine phosphatases.
Hoffman HE; Blair ER; Johndrow JE; Bishop AC
J Am Chem Soc; 2005 Mar; 127(9):2824-5. PubMed ID: 15740097
[TBL] [Abstract][Full Text] [Related]
12. Classification of inhibitors of protein tyrosine phosphatase 1B using molecular structure based descriptors.
Patankar SJ; Jurs PC
J Chem Inf Comput Sci; 2003; 43(3):885-99. PubMed ID: 12767147
[TBL] [Abstract][Full Text] [Related]
13. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
Rao GS; Ramachandran MV; Bajaj JS
J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
[TBL] [Abstract][Full Text] [Related]
14. PTP-1B inhibitors: cyclopenta[d][1,2]-oxazine derivatives.
Cho SY; Baek JY; Han SS; Kang SK; Ha JD; Ahn JH; Lee JD; Kim KR; Cheon HG; Rhee SD; Yang SD; Yon GH; Pak CS; Choi JK
Bioorg Med Chem Lett; 2006 Feb; 16(3):499-502. PubMed ID: 16289879
[TBL] [Abstract][Full Text] [Related]
15. LMW-PTP is a negative regulator of insulin-mediated mitotic and metabolic signalling.
Chiarugi P; Cirri P; Marra F; Raugei G; Camici G; Manao G; Ramponi G
Biochem Biophys Res Commun; 1997 Sep; 238(2):676-82. PubMed ID: 9299573
[TBL] [Abstract][Full Text] [Related]
16. Discovery of new potent human protein tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in silico screening.
Taha MO; Bustanji Y; Al-Bakri AG; Yousef AM; Zalloum WA; Al-Masri IM; Atallah N
J Mol Graph Model; 2007 Mar; 25(6):870-84. PubMed ID: 17035054
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of benzofuran scaffold-based potential PTP-1B inhibitors.
Dixit M; Tripathi BK; Tamrakar AK; Srivastava AK; Kumar B; Goel A
Bioorg Med Chem; 2007 Jan; 15(2):727-34. PubMed ID: 17095232
[TBL] [Abstract][Full Text] [Related]
18. 5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases.
Maccari R; Paoli P; Ottanà R; Jacomelli M; Ciurleo R; Manao G; Steindl T; Langer T; Vigorita MG; Camici G
Bioorg Med Chem; 2007 Aug; 15(15):5137-49. PubMed ID: 17543532
[TBL] [Abstract][Full Text] [Related]
19. LMW-PTP exerts a differential regulation on PDGF- and insulin-mediated signaling.
Taddei ML; Chiarugi P; Cirri P; Talini D; Camici G; Manao G; Raugei G; Ramponi G
Biochem Biophys Res Commun; 2000 Apr; 270(2):564-9. PubMed ID: 10753664
[TBL] [Abstract][Full Text] [Related]
20. Monocyclic thiophenes as protein tyrosine phosphatase 1B inhibitors: capturing interactions with Asp48.
Wan ZK; Lee J; Xu W; Erbe DV; Joseph-McCarthy D; Follows BC; Zhang YL
Bioorg Med Chem Lett; 2006 Sep; 16(18):4941-5. PubMed ID: 16806920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
